However, the difference in EVR rate between treatment-naïve patients and those who were previously treated by interferon-based therapies did not reach statistical significance ( P =.083) ( Table 3 ).
← all excerpts
Predictors of sustained virological response to a 48-week course of pegylated interferon alfa-2a and ribavirin in patients infected with hepatitis C virus genotype 4.
1
0.0830
0.0830